Humana Inc. (NYSE:HUM) Given Average Rating of “Hold” by Analysts

Shares of Humana Inc. (NYSE:HUM) have been assigned a consensus recommendation of “Hold” from the nineteen brokerages that are presently covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $424.50.

A number of equities analysts have recently issued reports on the stock. Stephens lowered their target price on shares of Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a research report on Friday, January 26th. TD Cowen reduced their target price on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a report on Tuesday, April 2nd. Bank of America restated a “neutral” rating and issued a $342.00 price target (down previously from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Truist Financial reiterated a “hold” rating and issued a $550.00 target price on shares of Humana in a research note on Friday, January 19th. Finally, Jefferies Financial Group decreased their price target on Humana from $411.00 to $381.00 and set a “buy” rating for the company in a report on Monday, April 22nd.

Insider Buying and Selling

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of Humana stock in a transaction on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the acquisition, the director now directly owns 2,578 shares of the company’s stock, valued at $946,358.02. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.32% of the company’s stock.

Institutional Trading of Humana

Large investors have recently made changes to their positions in the stock. Mariner LLC raised its position in shares of Humana by 2.3% in the third quarter. Mariner LLC now owns 14,119 shares of the insurance provider’s stock valued at $6,869,000 after buying an additional 312 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of Humana by 27.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider’s stock valued at $13,595,000 after purchasing an additional 6,034 shares during the period. Silverarc Capital Management LLC purchased a new position in Humana during the third quarter worth about $4,865,000. Vest Financial LLC grew its holdings in Humana by 43.3% in the 4th quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider’s stock valued at $12,815,000 after buying an additional 8,455 shares during the period. Finally, Artemis Investment Management LLP lifted its holdings in shares of Humana by 9.6% during the 4th quarter. Artemis Investment Management LLP now owns 64,573 shares of the insurance provider’s stock worth $29,563,000 after acquiring an additional 5,672 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $303.15 on Tuesday. The firm has a market capitalization of $36.53 billion, a PE ratio of 18.88, a price-to-earnings-growth ratio of 1.79 and a beta of 0.45. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The business’s fifty day moving average price is $326.86 and its 200 day moving average price is $393.28. Humana has a 12 month low of $299.23 and a 12 month high of $541.21.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $9.38 earnings per share. On average, sell-side analysts anticipate that Humana will post 16.08 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.17%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio (DPR) is 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.